Lung oncology Clinical Trials in Newnan, GA
As of August 2026, 10 paid clinical trials are recruiting for Lung oncology in Newnan, Georgia. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
10 clinical trials for Lung oncology
·Clear filters·Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Top Research Study Locations in Newnan
Researchers run research studies in Newnan, GA at 22 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| CTCA at Southeastern Regional Medical Center | Advanced Lung Non-Small Cell Carcinoma, Extensive Stage Lung Small Cell Carcinoma, Locally Advanced Cervical Adenocarcinoma | 8 |
| City of Hope Atlanta Cancer Center | Advanced Colon Adenocarcinoma, Advanced Colorectal Adenocarcinoma, Advanced Rectal Adenocarcinoma | 7 |
| Southeastern Regional Medical Center | Follicular Lymphoma, B-cell Malignancy, Chronic Lymphocytic Leukemia | 4 |
| City of Hope Atlanta | Extensive Stage Small-cell Lung Cancer, Hodgkin Lymphoma, Lymphoma | 3 |
| City of Hope National Medical Center, Atlanta Cancer Center | Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Chronic Lymphocytic Leukemia | 3 |
| Piedmont Newnan Hospital | Breast Cancer, Grade 2 Meningioma, Intracranial Meningioma | 3 |
| Vista Clinical Research | Chronic Migraine Headache, Degenerative Conditions of the Lumbar Spine, Headache (Migraine) | 3 |
| City Of Hope - Atlanta | Small Cell Lung Cancer, Multiple Myeloma, Hematologic Malignancies | 3 |
| City of Hope Cancer Center | Carcinoma, Non-Small-Cell Lung, Multiple Myeloma | 2 |
| Southeastern Regional Medical Center, Inc. dba City of Hope Atlanta | Relapsed or Refractory Large B-cell Lymphoma, Triple Negative Breast Cancer | 2 |
| Ambros Clinical Trial Site | Complex Regional Pain Syndrome Type I | 1 |
| Cancer Treatment Ctrs of America At | Lumbar Spinal Stenosis | 1 |
| City of Hope - Cancer Center Atlanta | Breast Cancer | 1 |
| City of Hope 1 | Carcinoma, Non-small-Cell Lung | 1 |
| City of Hope Cancer Center - Atlanta | Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms, Triple Negative Breast Neoplasms | 1 |
| City of Hope at Georgia - Atlanta | Lung Carcinoma | 1 |
| City of Hope® Atlanta | KRAS G12C Lung Cancer, Non-Small Cell Lung Cancer | 1 |
| Clinical Study Site | Metastatic Colorectal Cancer (CRC) | 1 |
| Georgia Bone and Joint | Shoulder Arthroplasty | 1 |
| Georgia Pain and Spine Care | Lumbar Spinal Stenosis | 1 |
| Newnan Surgery Center | Lumbar Spinal Stenosis | 1 |
| Vista Clinical Research/Summit Spine & Joint Centers | Osteoarthritic Knee Pain | 1 |
Active & Upcoming Studies in Newnan (2026)
Recruiting trials in Newnan grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (41 active studies)
- Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3 · Phase 2 · City of Hope Medical Center
- Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial · Phase 3 · City of Hope Medical Center
Neurology & pain (3 active studies)
- A Pivotal Clinical Study to Evaluate the MySalvia System for the Treatment of Resistant Migraine · Salvia BioElectronics
- Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE) · Phase 3 · Ambros Therapeutics, Inc.
Common conditions studied in Newnan
- Chronic Lymphocytic Leukemia (3 active studies)
- Multiple Myeloma (3 active studies)
- Small Lymphocytic Lymphoma (3 active studies)
- Breast Cancer (2 active studies)
- Breast Neoplasms (2 active studies)
- Carcinoma, Non-Small-Cell Lung (2 active studies)
Leading research sponsors in Newnan
- City of Hope Medical Center
- NRG Oncology
- National Cancer Institute (NCI)
- Amgen
- AstraZeneca
Frequently asked questions
How many paid clinical trials are currently recruiting in Newnan?
There are approximately 52 recruiting clinical trials in Newnan, Georgia listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Newnan pay participants?
Most recruiting trials in Newnan compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Newnan?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Newnan?
The most common conditions under active study in Newnan include Chronic Lymphocytic Leukemia (3), Multiple Myeloma (3), Small Lymphocytic Lymphoma (3), Breast Cancer (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Newnan?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Newnan on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Newnan?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Newnan?
Recruiting research sites in Newnan include CTCA at Southeastern Regional Medical Center, City of Hope Atlanta Cancer Center, Southeastern Regional Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Newnan right now?
The largest active categories in Newnan are Cancer & tumors (41), Neurology & pain (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.